EUR 0.07
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.09 EUR | 87.36% |
2022 | -0.72 EUR | -12.5% |
2021 | -0.64 EUR | 18.99% |
2020 | -0.79 EUR | -58.0% |
2019 | -0.50 EUR | 34.21% |
2018 | -0.76 EUR | 11.63% |
2017 | -0.86 EUR | -36.51% |
2016 | -0.63 EUR | -16.67% |
2015 | -0.54 EUR | -17.39% |
2014 | -0.46 EUR | -24.32% |
2013 | -0.37 EUR | -2883.87% |
2012 | -0.01 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.24 EUR | 0.0% |
2023 Q4 | -0.03 EUR | 0.0% |
2023 FY | - EUR | 87.24% |
2023 Q2 | -0.06 EUR | 0.0% |
2022 Q4 | -0.40 EUR | 0.0% |
2022 Q2 | -0.40 EUR | 0.0% |
2022 FY | - EUR | -12.5% |
2021 FY | - EUR | 18.99% |
2021 Q4 | -0.41 EUR | 0.0% |
2021 Q2 | -0.23 EUR | 0.0% |
2020 FY | - EUR | -58.0% |
2020 Q2 | -0.25 EUR | 0.0% |
2020 Q4 | -0.54 EUR | 0.0% |
2019 FY | - EUR | 34.21% |
2019 Q2 | -0.25 EUR | 0.0% |
2019 Q4 | -0.28 EUR | 0.0% |
2018 Q4 | -0.37 EUR | 0.0% |
2018 FY | - EUR | 11.63% |
2018 Q2 | -0.54 EUR | 0.0% |
2017 Q2 | -0.46 EUR | 0.0% |
2017 FY | - EUR | -36.51% |
2017 Q4 | -0.49 EUR | 0.0% |
2016 FY | - EUR | -16.67% |
2016 Q4 | -0.30 EUR | 0.0% |
2016 Q2 | -0.33 EUR | 0.0% |
2015 Q4 | -0.28 EUR | 0.0% |
2015 FY | - EUR | -17.39% |
2015 Q2 | -0.26 EUR | 0.0% |
2014 Q2 | -0.27 EUR | 0.0% |
2014 Q4 | -0.19 EUR | 0.0% |
2014 FY | - EUR | -24.32% |
2013 Q3 | -0.09 EUR | 46.76% |
2013 Q1 | -0.09 EUR | 0.0% |
2013 Q2 | -0.17 EUR | -87.85% |
2013 Q4 | -0.16 EUR | -76.8% |
2013 FY | - EUR | -2883.87% |
2012 Q3 | -0.00 EUR | 0.0% |
2012 Q1 | -0.00 EUR | 0.0% |
2012 FY | - EUR | 0.0% |
2012 Q4 | -0.09 EUR | -2819.35% |
2012 Q2 | -0.00 EUR | 0.0% |
2011 Q4 | -0.00 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
ABIONYX Pharma SA | -0.12 EUR | 24.167% |
ABIVAX Société Anonyme | -3.43 EUR | 97.347% |
Adocia SA | -1.91 EUR | 95.236% |
Aelis Farma SA | -0.39 EUR | 76.667% |
Biophytis S.A. | -12.55 EUR | 99.275% |
Advicenne S.A. | -0.67 EUR | 86.418% |
genOway Société anonyme | 0.17 EUR | 153.529% |
IntegraGen SA | -0.03 EUR | -251.351% |
Medesis Pharma S.A. | -0.80 EUR | 88.625% |
Neovacs S.A. | -0.00 EUR | -3540.0% |
NFL Biosciences SA | -0.46 EUR | 80.217% |
Plant Advanced Technologies SA | 0.07 EUR | 230.0% |
Sensorion SA | -0.17 EUR | 46.471% |
Theranexus Société Anonyme | -0.88 EUR | 89.659% |
TME Pharma N.V. | -1.34 EUR | 93.209% |
Valbiotis SA | -0.59 EUR | 84.576% |
TheraVet SA | -0.49 EUR | 81.429% |
Valerio Therapeutics Société anonyme | -0.15 EUR | 39.333% |
DBV Technologies S.A. | -0.71 EUR | 87.183% |
Genfit S.A. | -0.58 EUR | 84.31% |
GeNeuro SA | -0.59 EUR | 84.576% |
Innate Pharma S.A. | -0.09 EUR | 3.294% |
Inventiva S.A. | -2.43 EUR | 96.255% |
MaaT Pharma SA | -1.73 EUR | 94.74% |
MedinCell S.A. | -0.88 EUR | 89.659% |
Nanobiotix S.A. | -1.08 EUR | 91.574% |
OSE Immunotherapeutics SA | -1.18 EUR | 92.288% |
Poxel S.A. | -0.91 EUR | 90.0% |
GenSight Biologics S.A. | -0.54 EUR | 83.148% |
Transgene SA | -0.22 EUR | 58.636% |
Valneva SE | -0.73 EUR | 87.534% |